Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Allergy and Asthma Proceedings|June 11, 2020
Evaluation of daily patch application duration for epicutaneous immunotherapy for peanut allergyDavid M Fleischer, Jonathan M Spergel, Edwin H Kim, et al.
The Journal of Allergy and Clinical Immunology. in Practice|August 9, 2022
Peanut-Specific IgG4 and IgA in Saliva Are Modulated by Peanut Oral ImmunotherapyJohanna M Smeekens, Carolyn Baloh, Noha Lim, et al.
Molecular Nutrition & Food Research|September 14, 2023
Alanine Scanning of the Unstructured Region of Ara h 2 and of a Related Mimotope Reveals Critical Amino Acids for IgE BindingNicole Canon, Catherine H Schein, Werner Braun, et al.
Pediatrics|December 7, 2007
Clinical characteristics of peanut-allergic children: recent changesTodd D Green, Virginia S LaBelle, Pamela H Steele, et al.
The Journal of Allergy and Clinical Immunology|April 17, 2025
Baseline basophil activation and early suppression is associated with clinical outcome after peanut sublingual immunotherapyJessica R Humphrey, Rishu Guo, Xiaohong Yue, et al.
Allergy|March 24, 2026
Navigating Oral Food Challenges in Clinical Trials to Keep the Science Moving ForwardEdwin H Kim, J Andrew Bird, Helen A Brough, et al.
The Journal of Allergy and Clinical Immunology|February 24, 2023
Open-label study of the efficacy, safety, and durability of peanut sublingual immunotherapy in peanut-allergic childrenEdwin H Kim, Corinne A Keet, Yamini V Virkud, et al.
Medrxiv : the Preprint Server for Health Sciences|July 9, 2025
Association of bile acids, amino acids, and glycerophospholipid metabolites with food-allergic outcomes in children on peanut oral immunotherapyJennifer N Styles, Justin K Wang, Ananya Raman, et al.
The Journal of Allergy and Clinical Immunology|May 1, 2025
Fine resolution of the N-terminal IgE-binding epitope of Ara h 2: Discovery of variants with enhanced IgE bindingJoshua S Bernstein, Nicole Canon, Catherine H Schein, et al.
The Journal of Allergy and Clinical Immunology. in Practice|September 18, 2024
Omalizumab Implementation in Practice: Lessons Learned From the OUtMATCH StudyBrian P Vickery, J Andrew Bird, R Sharon Chinthrajah, et al.
Pageof 8